Treatment
Cabergoline clinical trials
We’re tracking 11 recruiting studies that include Cabergoline, each written for real people, not researchers, below.
Recruiting studies
- NCT07072910RecruitingPhase 2
Cabergoline for migraine prevention
This trial tests if a once-weekly medication called cabergoline can reduce how often you get migraine headaches. It is for adults who have between 4 and 14 migraine days per month.
Aarhus NAges 18 years+ - NCT07492160RecruitingPhase 2
Cabergoline for Breast Symptoms After Pregnancy Loss
This study tests whether a medication called cabergoline can help stop milk production and reduce breast discomfort after a pregnancy loss or abortion.
Brooklyn, New YorkAges 18 years+ - NCT07255911Recruiting
Comparing two medicines for ovulation in PCOS
This study tests if adding cabergoline to letrozole works better than letrozole alone to help women with PCOS ovulate. It may help participants who have not had success with standard treatments.
Dhaka, ShahbagAges 18–35 - NCT07043322RecruitingPhase 2
Cabergoline vs coasting for OHSS prevention
This study tests whether a medicine called cabergoline can lower the chance of ovarian hyperstimulation syndrome (OHSS) in women undergoing IVF who are at high risk. It compares cabergoline with a standard technique called 'coasting' (stopping fertility drugs for a few days).
Damietta, New DamiettaAges 20–35 - NCT07124221RecruitingPhase 3
Cabergoline vs Bromocriptine for High Prolactin Levels
This trial compares two medications, cabergoline and bromocriptine, to see which works better for women with high prolactin levels (hyperprolactinemia). It aims to find a more effective treatment to help manage this condition, which can affect fertility and menstrual cycles.
Beijing, Beijing MunicipalityAges 18–45 - NCT07463235RecruitingPhase 3
High dose cabergoline for small prolactin tumors in women
This trial tests a higher dose of the drug cabergoline to see if it works better for small prolactin-secreting tumors (microprolactinomas) in premenopausal women who have not been treated before. It aims to find a safe and effective way to lower high prolactin levels and shrink the tumor.
Belo HorizonteAges 18 years+ - NCT07603466Enrolling by invitationPhase 4
Two drugs combined to treat Cushing's disease
This trial tests whether taking two medications together—osilodrostat and cabergoline—can help control Cushing's disease by lowering excess cortisol levels. Cushing's disease is caused by a pituitary tumor that makes too much of a hormone called ACTH, which drives cortisol overproduction.
BasraAges 18–70 - NCT07034859Enrolling by invitationPhase 4
Cabergoline for nonfunctioning pituitary tumors
This trial tests if cabergoline, a medicine, can help shrink nonfunctioning pituitary adenomas (benign tumors on the pituitary gland that don't produce excess hormones). It may be an option for people who have not had prior radiation or surgery, and whose tumors are at least 0.5 cm in size.
Taipei, TaiwanAges 18 years+ - NCT06123026RecruitingPhase 4
Medication to stop breast milk after 16–20 week abortion
This study tests a medication given after a second-trimester abortion (16–20 weeks) to see if it can safely and effectively stop the body from producing breast milk. It also wants to learn how well people tolerate the medicine.
Chicago, IllinoisAges 18–50 - NCT07045935RecruitingPhase 4
Metabolic effects of cabergoline in prolactinoma patients
This study looks at metabolic health (like blood sugar and cholesterol) in people with prolactinomas who are being treated with the drug cabergoline. It aims to understand how lowering prolactin affects the body's metabolism and may help guide better care for patients with this condition.
BaselAges 18 years+ - NCT07568574Enrolling by invitation
Medical Study of Performance-Enhancing Substances in Elite Athletes
This study looks at how medically supervised performance-enhancing substances affect elite athletes' health and quality of life. Participants must be retired from professional sports and willing to undergo careful medical monitoring throughout the trial.
Abu DhabiAges 18 years+
What Cabergoline is being studied for
Conditions with recruiting Cabergoline studies.
Common questions
- Are there clinical trials studying Cabergoline?
- Yes. Clin2 currently lists 11 recruiting studies that include Cabergoline, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Cabergoline trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Cabergoline an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Cabergoline or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.